Celon Pharma SA's market cap is currently €272.44M. The company's EPS TTM is €-0.14455569599999998; its P/E ratio is 64.71; Celon Pharma SA is scheduled to report earnings on September 17, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
